Drug Abuse Testing Market: By Sample Type, By Technology, By Drug Class and Region Forecast 2019-2030

Drug Abuse Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Sample Type (Urine, Saliva, Hair, Blood, Others), By Technology (Immunoassay, Onsite Testing, Mass Spectrometry, Others), By Drug Class (Amphetamines, Barbiturates, Cannabinoids, Cocaine, Alcohol Abuse, Heroin Substitution Panel, LSD, Designer Drugs, Benzodiazepines, Opiates, Antidepressants) and Region Forecast 2019-2030

Drug Abuse Testing (DAT) Market size is valued at US$ 2,507.4 million in 2023 and is expected to reach US$ 3,307.3 million by 2029, at a CAGR of 3.9% from 2024-2030. The workforce drug testing and drug abuse cases mainly drive the drug abuse testing market. The growth of the drug abuse testing (DAT) market is attributed to the increase in usage of alcohol, cannabinoids, cocaine, amphetamines, opiates, and other illicit drugs in various countries across the globe. The top five drug classes are amphetamines, opiates, alcohol, cocaine, and cannabis, accounting for an 80.8% market share in the global drug abuse testing (DAT) market. The urine sample is highly preferred for initial screening and confirmation.

Drug Abuse Testing Market

However, the adoption of saliva samples for screening is expected to create lucrative opportunities over the future years due to the manipulation or adulteration of urine samples with synthetic urine by drug abusers. Forensic laboratories prefer hair samples, which may be given for substances abused 90 days back. However, if the person has no hair or short hair, forensic laboratories prefer a nail test. For the majority of urine and saliva samples, immunoassay and onsite testing are highly preferred for initial screening, and positive samples should be confirmed by mass spectrometry.

Key Developments:

In Sept 2019, A new distribution contract was signed by Psychemedics Corporation with Toxicologia Pardini Ltda. and Sanso Holding S.A. in Brazil. Toxicologia Pardini and Sanso was chosen as the Brazilian distributor for Psychemedics' hair drug testing services under the terms of the new deal.

Download Free Sample

Drug Abuse Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

3.9%

Largest Market

North-America

Fastest Growing Market

North America

Drug Abuse Testing (DAT) Market Dynamics

A growing number of drug users across the globe is responsible for the growth of the drug abuse testing market. The increase in the consumption of alcohol and other illicit drugs such as cannabis, cocaine, heroin, and opiates is a major factor in the growth of the global drug abuse testing market over the forecast years. For instance, according to UNODC 2021, approximately 296 Million people had used drugs per year. However, the number of drugs is gradually increasing due to the rapid growth in population, and unemployment is contributing to drug abuse testing growth around the world. Cannabis is a highly used illicit drug, with an estimated approximately 219 Million people per year around the world. In 2021, approximately 36 Million used amphetamines, 22 million used cocaine, and 20 million used ecstasy. In addition, according to UNODC 2021 data, opioids contribute to drug-related harm that includes fatal overdoses. Around 60 million people engaged in non-medical opioid use in 2021, and 31.5 million used mainly opiates (heroin).

North-America Got Significant Share

Drug Abuse Testing (DAT) Market Regional Analysis

The North American drug abuse testing (DAT) market dominates with a 56% market share in terms of the number of tests, followed by Europe and Asia Pacific. In the European region, the UK carries out more than 16 million drug abuse tests every year. In terms of the market value, the USA Drug abuse testing market was valued at USD 1,297.3 million in 2023 and projected to reach USD 1,598.0 million by 2029.

In the United States (USA), amphetamines dominated the drug abuse testing (DAT) market in 2023 with an approximate share of 20%, followed by Opiates with 18%, Alcohol Abuse with 15%, and Cannabinoids with 14% share.

Among all the amphetamines, Methamphetamine was the most frequently identified drug, followed by Amphetamine, N-ethylpentylone, and MDMA. Amphetamine abuse is increasing in the USA due to a surge in the number of Amphetamine prescriptions for certain diseases such as obesity, narcolepsy, or attention deficit hyperactivity disorder (ADHD). Opiates contributed the second largest share in the USA. Opioid abuse increased till 2016 due to a surge in the adoption of prescription pain relievers such as hydrocodone, oxycodone, oxymorphone, morphine, codeine, fentanyl, and others, which are widely prescribed for moderate to severe pain.

Latin America

Europe

Asia Pacific

Middle East

North America

Drug Abuse Testing Market Segmentation Analysis

Report Benchmarks	Details
Report Study Period	2024-2030
Market Size in 2023	US$ 2,507.4 million
Market Size in 2029	US$ 3,307.3 million
Market CAGR	3.9%
By Sample	Urine Saliva Hair Blood Others
By Technology	Immunoassay Onsite Testing Mass Spectrometry Others
By Drug Class	Amphetamines Barbiturates Cannabinoids Cocaine Alcohol Abuse Heroin Substitution Panel LSD Designer Drugs Benzodiazepines Opiates Antidepressants
By Region	North America (U.S., Canada) Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific) Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America) Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

The drug abuse testing market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments, and start-up details that are actively working in the market
The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

Every year, approximately 222 Million drug abuse tests take place across the globe.

Abbott Laboratories, Danaher Corporation (Beckman Coulter), LabCorp, Dragerwerk AG & Co. KGaA, Quest Diagnostics Inc.

North America is the fastest-growing region for Drug Abuse Testing Market

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary

2. Global Drug Abuse Testing Market Introduction

2.1. Global Drug Abuse Testing Market – Taxonomy

2.1.1. Drug Class Type

2.1.2. Sample Type

2.1.3. Technology

2.1.4. Region

3. Global Drug Abuse Testing Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Drug Abuse Testing Market – Competition Landscape

4. Global Drug Abuse Testing Market Snapshot, 2023

4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. USA Drug Abuse Testing Market, 2019 - 2023 and Forecast, 2024 - 2030 (Volume and Value)

5.1. Volume Breakdown by Sample Type – 2023

5.1.1. Urine

5.1.2. Saliva

5.1.3. Hair

5.1.4. Blood

5.1.5. Others

5.2. Volume Breakdown by Technology – 2023

5.2.1. Immunoassay

5.2.2. Onsite Testing

5.2.3. Mass Spectrometry

5.2.4. Others

5.3. Drug Abuse Testing Market - 2023, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)

5.3.1. Amphetamines

5.3.2. Barbiturates

5.3.3. Cannabinoids

5.3.4. Cocaine

5.3.5. Alcohol Abuse

5.3.6. Heroin Substitution Panel

5.3.7. LSD

5.3.8. Designer Drugs

5.3.9. Benzodiazepines

5.3.10. Opiates

5.3.11. Antidepressants

6. Canada Drug Abuse Testing Market, 2019 - 2023 and Forecast, 2024 - 2030 (Volume and Value)

6.1. Volume Breakdown by Sample Type – 2023

6.1.1. Urine

6.1.2. Saliva

6.1.3. Hair

6.1.4. Blood

6.1.5. Others

6.2. Volume Breakdown by Technology – 2023

6.2.1. Immunoassay

6.2.2. Onsite Testing

6.2.3. Mass Spectrometry

6.2.4. Others

6.3. Drug Abuse Testing Market - 2023, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)

6.3.1. Amphetamines

6.3.2. Barbiturates

6.3.3. Cannabinoids

6.3.4. Cocaine

6.3.5. Alcohol Abuse

6.3.6. Heroin Substitution Panel

6.3.7. LSD

6.3.8. Designer Drugs

6.3.9. Benzodiazepines

6.3.10. Opiates

6.3.11. Antidepressants

7. Germany Drug Abuse Testing Market, 2019 - 2023 and Forecast, 2024 - 2030 (Volume and Value)

7.1. Volume Breakdown by Sample Type – 2023

7.1.1. Urine

7.1.2. Saliva

7.1.3. Hair

7.1.4. Blood

7.1.5. Others

7.2. Volume Breakdown by Technology – 2023

7.2.1. Immunoassay

7.2.2. Onsite Testing

7.2.3. Mass Spectrometry

7.2.4. Others

7.3. Drug Abuse Testing Market - 2023, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)

7.3.1. Amphetamines

7.3.2. Barbiturates

7.3.3. Cannabinoids

7.3.4. Cocaine

7.3.5. Alcohol Abuse

7.3.6. Heroin Substitution Panel

7.3.7. LSD

7.3.8. Designer Drugs

7.3.9. Benzodiazepines

7.3.10. Opiates

7.3.11. Antidepressants

8. France Drug Abuse Testing Market, 2019 - 2023 and Forecast, 2024 - 2030 (Volume and Value)

8.1. Volume Breakdown by Sample Type – 2023

8.1.1. Urine

8.1.2. Saliva

8.1.3. Hair

8.1.4. Blood

8.1.5. Others

8.2. Volume Breakdown by Technology – 2023

8.2.1. Immunoassay

8.2.2. Onsite Testing

8.2.3. Mass Spectrometry

8.2.4. Others

8.3. Drug Abuse Testing Market - 2023, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)

8.3.1. Amphetamines

8.3.2. Barbiturates

8.3.3. Cannabinoids

8.3.4. Cocaine

8.3.5. Alcohol Abuse

8.3.6. Heroin Substitution Panel

8.3.7. LSD

8.3.8. Designer Drugs

8.3.9. Benzodiazepines

8.3.10. Opiates

8.3.11. Antidepressants

9. UK Drug Abuse Testing Market, 2019 - 2023 and Forecast, 2024 - 2030 (Volume and Value)

9.1. Volume Breakdown by Sample Type – 2023

9.1.1. Urine

9.1.2. Saliva

9.1.3. Hair

9.1.4. Blood

9.1.5. Others

9.2. Volume Breakdown by Technology – 2023

9.2.1. Immunoassay

9.2.2. Onsite Testing

9.2.3. Mass Spectrometry

9.2.4. Others

9.3. Drug Abuse Testing Market - 2023, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)

9.3.1. Amphetamines

9.3.2. Barbiturates

9.3.3. Cannabinoids

9.3.4. Cocaine

9.3.5. Alcohol Abuse

9.3.6. Heroin Substitution Panel

9.3.7. LSD

9.3.8. Designer Drugs

9.3.9. Benzodiazepines

9.3.10. Opiates

9.3.11. Antidepressants

9.3.12. Methaqualone

10. Italy Drug Abuse Testing Market, 2019 - 2023 and Forecast, 2024 - 2030 (Volume and Value)

10.1. Volume Breakdown by Sample Type – 2023

10.1.1. Urine

10.1.2. Saliva

10.1.3. Hair

10.1.4. Blood

10.1.5. Others

10.2. Volume Breakdown by Technology – 2023

10.2.1. Immunoassay

10.2.2. Onsite Testing

10.2.3. Mass Spectrometry

10.2.4. Others

10.3. Drug Abuse Testing Market - 2023, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)

10.3.1. Amphetamines

10.3.2. Cannabinoids

10.3.3. Cocaine

10.3.4. Alcohol Abuse

10.3.5. Heroin Substitution Panel

10.3.6. Benzodiazepines

10.3.7. Opiates

10.3.8. Antidepressants

11. Spain Drug Abuse Testing Market, 2019 - 2023 and Forecast, 2024 - 2030 (Volume and Value)

11.1. Volume Breakdown by Sample Type – 2023

11.1.1. Urine

11.1.2. Saliva

11.1.3. Hair

11.1.4. Blood

11.1.5. Others

11.2. Volume Breakdown by Technology – 2023

11.2.1. Immunoassay

11.2.2. Onsite Testing

11.2.3. Mass Spectrometry

11.2.4. Others

11.3. Drug Abuse Testing Market - 2023, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)

11.3.1. Amphetamines

11.3.2. Barbiturates

11.3.3. Cannabinoids

11.3.4. Cocaine

11.3.5. Alcohol Abuse

11.3.6. Heroin Substitution Panel

11.3.7. LSD

11.3.8. Designer Drugs

11.3.9. Benzodiazepines

11.3.10. Opiates

11.3.11. Antidepressants

12. Switzerland Drug Abuse Testing Market, 2019 - 2023 and Forecast, 2024 - 2030 (Volume and Value)

12.1. Volume Breakdown by Sample Type – 2023

12.1.1. Urine

12.1.2. Saliva

12.1.3. Hair

12.1.4. Blood

12.1.5. Others

12.2. Volume Breakdown by Technology – 2023

12.2.1. Immunoassay

12.2.2. Onsite Testing

12.2.3. Mass Spectrometry

12.2.4. Others

12.3. Drug Abuse Testing Market - 2023, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)

12.3.1. Amphetamines

12.3.2. Barbiturates

12.3.3. Cannabinoids

12.3.4. Cocaine

12.3.5. Alcohol Abuse

12.3.6. Heroin Substitution Panel

12.3.7. LSD

12.3.8. Designer Drugs

12.3.9. Benzodiazepines

12.3.10. Opiates

12.3.11. Antidepressants

13. Austria Drug Abuse Testing Market, 2019 - 2023 and Forecast, 2024 - 2030 (Volume and Value)

13.1. Volume Breakdown by Sample Type – 2023

13.1.1. Urine

13.1.2. Saliva

13.1.3. Hair

13.1.4. Blood

13.1.5. Others

13.2. Volume Breakdown by Technology – 2023

13.2.1. Immunoassay

13.2.2. Onsite Testing

13.2.3. Mass Spectrometry

13.2.4. Others

13.3. Drug Abuse Testing Market - 2023, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)

13.3.1. Amphetamines

13.3.2. Barbiturates

13.3.3. Cannabinoids

13.3.4. Cocaine

13.3.5. Alcohol Abuse

13.3.6. Heroin Substitution Panel

13.3.7. LSD

13.3.8. Designer Drugs

13.3.9. Benzodiazepines

13.3.10. Opiates

13.3.11. Antidepressants

14. China Drug Abuse Testing Market, 2019 - 2023 and Forecast, 2024 - 2030 (Volume and Value)

14.1. Volume Breakdown by Sample Type – 2023

14.1.1. Urine

14.1.2. Saliva

14.1.3. Hair

14.1.4. Blood

14.1.5. Others

14.2. Volume Breakdown by Technology – 2023

14.2.1. Immunoassay

14.2.2. Onsite Testing

14.2.3. Mass Spectrometry

14.2.4. Others

14.3. Drug Abuse Testing Market - 2023, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)

14.3.1. Amphetamines

14.3.2. Barbiturates

14.3.3. Cannabinoids

14.3.4. Cocaine

14.3.5. Alcohol Abuse

14.3.6. Heroin Substitution Panel

14.3.7. LSD

14.3.8. Designer Drugs

14.3.9. Benzodiazepines

14.3.10. Opiates

14.3.11. Antidepressants

15. Korea Drug Abuse Testing Market, 2019 - 2023 and Forecast, 2024 - 2030 (Volume and Value)

15.1. Volume Breakdown by Sample Type – 2023

15.1.1. Urine

15.1.2. Saliva

15.1.3. Hair

15.1.4. Blood

15.1.5. Others

15.2. Volume Breakdown by Technology – 2023

15.2.1. Immunoassay

15.2.2. Onsite Testing

15.2.3. Mass Spectrometry

15.2.4. Others

15.3. Drug Abuse Testing Market - 2023, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)

15.3.1. Amphetamines

15.3.2. Barbiturates

15.3.3. Cannabinoids

15.3.4. Cocaine

15.3.5. Alcohol Abuse

15.3.6. Heroin Substitution Panel

15.3.7. LSD

15.3.8. Designer Drugs

15.3.9. Benzodiazepines

15.3.10. Opiates

15.3.11. Antidepressants

16. Australia Drug Abuse Testing Market, 2019 - 2023 and Forecast, 2024 - 2030 (Volume and Value)

16.1. Volume Breakdown by Sample Type – 2023

16.1.1. Urine

16.1.2. Saliva

16.1.3. Hair

16.1.4. Blood

16.1.5. Others

16.2. Volume Breakdown by Technology – 2023

16.2.1. Immunoassay

16.2.2. Onsite Testing

16.2.3. Mass Spectrometry

16.2.4. Others

16.3. Drug Abuse Testing Market - 2023, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)

16.3.1. Amphetamines

16.3.2. Cannabinoids

16.3.3. Cocaine

16.3.4. Alcohol Abuse

16.3.5. Heroin Substitution Panel

16.3.6. Designer Drugs

16.3.7. Benzodiazepines

16.3.8. Opiates

16.3.9. Antidepressants

17. Brazil Drug Abuse Testing Market, 2019 - 2023 and Forecast, 2024 - 2030 (Volume and Value)

17.1. Volume Breakdown by Sample Type – 2023

17.1.1. Urine

17.1.2. Saliva

17.1.3. Hair

17.1.4. Blood

17.1.5. Others

17.2. Volume Breakdown by Technology – 2023

17.2.1. Immunoassay

17.2.2. Onsite Testing

17.2.3. Mass Spectrometry

17.2.4. Others

17.3. Drug Abuse Testing Market - 2023, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)

17.3.1. Amphetamines

17.3.2. Barbiturates

17.3.3. Cannabinoids

17.3.4. Cocaine

17.3.5. Alcohol Abuse

17.3.6. Heroin Substitution Panel

17.3.7. Designer Drugs

17.3.8. Benzodiazepines

17.3.9. Opiates

17.3.10. Antidepressants

18. Central America Drug Abuse Testing Market, 2019 - 2023 and Forecast, 2024 - 2030 (Volume and Value)

18.1. Volume Breakdown by Sample Type – 2023

18.1.1. Urine

18.1.2. Saliva

18.1.3. Hair

18.1.4. Blood

18.1.5. Others

18.2. Volume Breakdown by Technology – 2023

18.2.1. Immunoassay

18.2.2. Onsite Testing

18.2.3. Mass Spectrometry

18.2.4. Others

18.3. Drug Abuse Testing Market - 2023, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)

18.3.1. Amphetamines

18.3.2. Barbiturates

18.3.3. Cannabinoids

18.3.4. Cocaine

18.3.5. Alcohol Abuse

18.3.6. Heroin Substitution Panel

18.3.7. LSD

18.3.8. Designer Drugs

18.3.9. Benzodiazepines

18.3.10. Opiates

18.3.11. Antidepressants

19. Competition Landscape

19.1. Accuquik Test Kits

19.2. Advin Biotech

19.3. Alere, Inc. (Abbott)

19.4. Alfa Scientific Designs, Inc.

19.5. Andatech

19.6. ARK Diagnostics

19.7. Biopanda Reagents

19.8. Beckman Coulter

19.9. BTNX, Inc.

19.10. Corolina Liquid Chemistries

19.11. Chromsystems, Inc.

19.12. Co-Innovation Biotech Co., Ltd.

19.13. Confirm Biosciences

19.14. Diagnostic Automation/Cortez Diagnostics Inc.

19.15. Diasystems Scandinevia AB

19.16. Germaine Laboratories, Inc.

19.17. Innovative Testing Solution

19.18. Immunostics, Inc.

19.19. Medacx Ltd.

19.20. Meridian Healthcare srl

19.21. Mossman Associates

19.22. Neogen Corporation

19.23. Orasure Technologies, Inc.

19.24. Pharmatech, Inc.

19.25. Premier Biotech

19.26. Prospectol

19.27. Sekisui Diagnostics

19.28. Siemens Healthineers

19.29. Thermo Fisher Scientific, Inc.

20. Research Methodology

21. Appendix and Abbreviations

Key Market Players

Accuquik Test Kits
Advin Biotech
Alere, Inc. (Abbott)
Alfa Scientific Designs, Inc.
Andatech
ARK Diagnostics
Biopanda Reagents
Beckman Coulter
BTNX, Inc.
Corolina Liquid Chemistries
Chromsystems, Inc.
Co-Innovation Biotech Co., Ltd.
Confirm Biosciences
Diagnostic Automation/Cortez Diagnostics Inc.
Diasystems Scandinevia AB
Germaine Laboratories, Inc.
Innovative Testing Solution
Immunostics, Inc.
Medacx Ltd.
Meridian Healthcare srl
Mossman Associates
Neogen Corporation
Orasure Technologies, Inc.
Pharmatech, Inc.
Premier Biotech
Prospectol
Sekisui Diagnostics
Siemens Healthineers
Thermo Fisher Scientific, Inc.

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market